Neurodegenerative Diseases

Papers
(The median citation count of Neurodegenerative Diseases is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
The Immunomodulatory Potential Role of Mesenchymal Stem Cells in Diseases of the Central Nervous System31
Publisher's Note12
Sex Differences for Social Determinants Associated with Lewy Body Dementia Onset and Diagnosis8
Alzheimer's disease, β-amyloid peptides and ubiquitin-proteasome system: nutritherapeutic insights6
A review of sex differences in neurodegeneration and psychological comorbidities in MS and related disorders6
A Pivotal Time5
The Impact of Drug Interactions on the Results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes5
Contents Vol. 22, 20225
Age of Onset and Length of Survival of Queensland Patients with Amyotrophic Lateral Sclerosis: Details of Subjects with Early Onset and Subjects with Long Survival4
Front & Back Matter3
Contents Vol. 23, 20233
Subjective Sleep Disturbance and Lewy Pathology: Data from a Cohort of Essential Tremor Brain Donors3
Contents Vol. 24, 20243
Front & Back Matter3
Early Autonomic Symptoms Predict Functional Decline in Parkinson’s Disease Independent of Dopaminergic Therapy2
Huntington’s Disease in Hospitalized Patients Infected with SARS-CoV-2 in Brazil: Three-Year Update2
A Paradigm Shift in the Management of Patients with Parkinson’s Disease2
XXXth Congress of Société Francophone Posture Equilibre et Locomotion, Paris, France, 5-6 December 2024 - Abstracts2
Epidemiological Impact of Neurodegenerative Diseases in the Rural Spanish-Portuguese Cross-Border Region1
Hippocampal Functional Connectivity in Parkinson’s Disease1
CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer’s Disease1
Dual-Task Performance and Brain Morphologic Characteristics in Parkinson’s Disease1
The Two-Way Route between Delirium Disorder and Dementia: Insights from COVID-191
Locus Coeruleus sexual dimorphism and its impact on cognitive impairment and cortical atrophy in Alzheimer’s Disease1
A Decision-Making Algorithm for Remote Digital Assessments of Alzheimer’s Disease0
New editorship of Neurodegenerative Diseases0
Synaptic Neurofilaments and GluN1-Neurofilament Light Chain Interaction in Experimental Models of α-Synucleinopathies0
The Taxonomy of Subjective Cognitive Decline: Proposal and First Clinical Evidence from the Geneva Memory Clinic Cohort0
Acknowledgement to Reviewers0
Differential Effects of Disease Duration and Dopaminergic Replacement Therapy on Vocal Emotion Recognition in Asymmetric Parkinson’s Disease0
Front & Back Matter0
Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population0
Verbal Learning Impairment in Parkinson’s Disease: Role of the Frontostriatal System in Working and Strategic Memory0
Sex differences in progression of neurodegeneration: the AGES-Reykjavik Study0
Clinical Manifestations Associated with the Domain-Containing Protein 2 Gene Mutation in an Iranian Family with Spastic Paraplegia 540
Potential Correlation between Tea Intake and the Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study0
Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer’s Disease and Related Dementia0
Predicting the Rapid Progression of Mild Cognitive Impairment by Intestinal Flora and Blood Indicators through Machine Learning Method0
4-Phthalimidobenzenesulfonamide Derivatives as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: DFTs, 3D-QSAR, ADMET, and Molecular Dynamics Simulation0
Anti-amyloid monoclonal antibodies for the treatment of Alzheimer disease: Intersocietal recommendations for their appropriate use in Switzerland0
Natural Age-Related Slow-Wave Sleep Alterations Onset Prematurely in the Tg2576 Mouse Model of Alzheimer’s Disease0
Whole Exome Sequencing Indicating GGCCTG Hexanucleotide Repeat in Patients with Spinocerebellar Ataxia Type 360
Serum Neurofilament Light-Chain Levels in Essential Tremor: A Replication Study0
Anti-amyloid treatments, a therapeutic revolution, ready for Europe0
Acknowledgement to Reviewers0
CSF Aβ40 and P-Tau181 Might Differentiate Atypical from Typical AD Phenotypes: Preliminary Evidence0
Baseline Depressive Symptoms as a Predictor of Incident Dementia in a Prospectively Followed Cohort of Elders with Essential Tremor0
Front & Back Matter0
White Matter Hyperintensities Are Associated with Slower Gait Speed in Older Adults without Dementia0
20th Anniversary of <i>Neurodegenerative Diseases</i>: A Parallel (R)Evolution between the 20th and the 21st Century?0
Acknowledgement to Reviewers0
Neuroimaging and Neurodegeneration0
Neurology of Aging: Adapting Neurology Provision for an Aging Population0
Society News0
Frontostriatal Circuits Alterations Associated with Cognitive Flexibility Deterioration in Huntington’s Disease0
Heart Rate Variability in Huntington Disease: A Long-Term Longitudinal Study0
Distinct Patterns of Brain Atrophy in Amnestic Mild Cognitive Impairment and Motoric Cognitive Risk Syndromes0
Association between Gut Microbiota with Mild Cognitive Impairment and Alzheimer’s Disease in a Thai Population0
Anti-amyloid drugs for Alzheimer’s disease: considering the role of depression0
Ecological Validity of the Montreal Cognitive Assessment in Non-Demented Parkinson’s Disease Patients0
Cerebral Tau Deposition in Comorbid Progressive Supranuclear Palsy and Amyotrophic Lateral Sclerosis: An [<sup>18</sup>F]-Flortaucipir and 7T MRI Study0
Circulating Biomarkers for Alzheimer’s Disease: Unlocking the Diagnostic Potential in Low- and Middle-Income Countries, Focusing on Africa0
Classification of Mild Cognitive Impairment and Alzheimer’s Disease Using Manual Motor Measures0
0.096987009048462